West Branch Capital’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-754
| Closed | -$10.2K | – | 447 |
|
|
2023
Q2 | $10.2K | Buy |
754
+17
| +2% | +$230 | 0.01% | 280 |
|
|
2023
Q1 | $10.3K | Buy |
737
+18
| +3% | +$251 | 0.01% | 286 |
|
|
2022
Q4 | $10.2K | Buy |
719
+15
| +2% | +$213 | 0.01% | 281 |
|
|
2022
Q3 | $10K | Buy |
704
+15
| +2% | +$213 | 0.01% | 285 |
|
|
2022
Q2 | $10K | Buy |
689
+17
| +3% | +$247 | 0.01% | 278 |
|
|
2022
Q1 | $11K | Buy |
672
+16
| +2% | +$262 | 0.01% | 289 |
|
|
2021
Q4 | $13K | Buy |
656
+14
| +2% | +$277 | 0.01% | 300 |
|
|
2021
Q3 | $13K | Buy |
642
+12
| +2% | +$243 | 0.01% | 284 |
|
|
2021
Q2 | $13K | Buy |
+630
| New | +$13K | 0.01% | 300 |
|